Patent · US Active

Process for the manufacture of Sevoflurane

US8987524B2 · kind B2 · utility

0Cited by
11References
24Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 10, 2010
Grant dateMar 24, 2015
Priority date
Expiry dateOct 19, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C67/31
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A process for the manufacture of Sevoflurane CF3—CH(OCH2F)—CF3 which comprises (a) manufacturing a substituted malonic acid derivative of formula (I): R1OOC—CH(OCH2X)—COOR2 or of formula (II): R3HNOC—CH(OCH2X)—CONHR4, wherein X is OH or a leaving group which can be substituted by nucleophilic substitution and wherein R1, R2 R3, R4, equal to or different from each other, are independently selected from the group consisting of H, an alkyl group having from 1 to 10 carbon atoms which is optionally substituted by at least one halogen atom, an aralkyl group, and an aryl group; and (b) further reacting said malonic acid derivative as intermediate for the manufacture of Sevoflurane CF3—CH(OCH2F)—CF3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.